Dan Tierno BS, MBA, MA

Mr. Dan Tierno has over 20 years of experience in pharmaceutical portfolio management, R&D and commercialization. Mr. Tierno also specializes in cell and gene editing technologies, mHealth, and strategies for use of advanced analytics in clinical trials. Mr. Tierno has spoken on the following topics: training scientists for rare disease therapeutic development, impacts of genomics in clinical trial design for cell and gene therapies, and defining and generating value via portfolio management. In 2019, topics Mr. Tierno will be speaking on include innovative models for cell and gene therapy clinical trials, funding and payer models for novel therapeutics, and the relationship between STEM programs in early education and entrepreneurship. Mr. Tierno holds his B.S. in Nutrition Science from New York Institute of Technology, his Honors M.B.A. from the Zicklin School of Business at Baruch College, and his M.A. in Biotechnology from Columbia University.